News on B. Braun Melsungen AG from BioPortfolio.com http://www.BioPortfolio.com Consolidated B. Braun Melsungen AG news from BioPortfolio.com Wed, 10 Feb 2010 14:16:11 GMT en MEDRAD - B. Braun: Co-marketing & Trademark License Agreementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994489&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994489&THISHREF=http://c.moreover.com/click/here.pl%3fz2515060060%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994489&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994489&THISHREF=http://c.moreover.com/click/here.pl%3fz2515060060%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicexchange.com: MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985057&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985057&THISHREF=http://c.moreover.com/click/here.pl%3fz2508452432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3985057&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3985057&THISHREF=http://c.moreover.com/click/here.pl%3fz2508452432%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Medrad and B Braun Melsungen sign licensing agreementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976226&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976226&THISHREF=http://c.moreover.com/click/here.pl%3fz2504303072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976226&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976226&THISHREF=http://c.moreover.com/click/here.pl%3fz2504303072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Medrad and B Braun Melsungen Sign Licensing Agreementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979139&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979139&THISHREF=http://c.moreover.com/click/here.pl%3fz2505660671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979139&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979139&THISHREF=http://c.moreover.com/click/here.pl%3fz2505660671%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: Medrad and B Braun Melsungen sign licensing agreementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977814&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977814&THISHREF=http://c.moreover.com/click/here.pl%3fz2504977000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977814&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977814&THISHREF=http://c.moreover.com/click/here.pl%3fz2504977000%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972370&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972370&THISHREF=http://c.moreover.com/click/here.pl%3fz2502360440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972370&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972370&THISHREF=http://c.moreover.com/click/here.pl%3fz2502360440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972047&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972047&THISHREF=http://c.moreover.com/click/here.pl%3fz2502200174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972047&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972047&THISHREF=http://c.moreover.com/click/here.pl%3fz2502200174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: B. Braun To Invest Another 1.6bn Euroshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3881960&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3881960&THISHREF=http://c.moreover.com/click/here.pl%3fz2454202461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3881960&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3881960&THISHREF=http://c.moreover.com/click/here.pl%3fz2454202461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: B Braun obtains preliminary injunction against Poly Medicure in Germanyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3763385&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3763385&THISHREF=http://c.moreover.com/click/here.pl%3fz2392244727%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3763385&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=B.%20Braun%20Melsungen%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3763385&THISHREF=http://c.moreover.com/click/here.pl%3fz2392244727%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: